FMFlorence Momplaisir

Florence Momplaisir

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florence Momplaisir has a total of 156 co-authors. Here are the top co-authors by number of shared publications:

  • Hervette Nkwihoreze

    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania

    7 shared publications
  • Helen Koenig

    Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

    3 shared publications
  • Angela K. Shen

    Vaccine Education Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

    2 shared publications
  • Barbara J. Kuter

    Vaccine Education Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States

    2 shared publications
  • David Bennett

    Department of Psychiatry, Drexel University School of Medicine, Philadelphia, Pennsylvania, USA

    2 shared publications
  • Fatemeh Ghadimi

    Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA

    2 shared publications

Latest Publications

  • A Meta-Synthesis on Perceptions of Possibility for HIV Infection Among Cisgender and Heterosexual Women

    by Emily R. Alpert, Jacqueline Kent-Marvick, Omaris Caceres, Aidan Perner, Florence M. Momplaisir, Sarita Sonalkar, Shimrit Keddem

    Introduction: Nineteen percent of new HIV diagnoses in the United States in 2022 occurred in women. One barrier to HIV prevention is low perception of possibility of infection. We explored the qualitative data on perception of chances of HIV infection in women to elucidate how women conceive potential for infection. Methods: Included articles were published between 2014 and 2024 with information on women, HIV, and perception of potential for infection. The codebook was created from emerging and theoretical constructs. Articles were coded using Dedoose. Codes were reviewed for cross-cutting themes and summaries created. Confidence in review findings was assessed with the CERQual approach. Results: The meta-synthesis included 20 papers. These included 4 papers focused on women engaged in substance use and 5 focused on Black individuals. Four themes emerged: women controlled aspects of their lives and altered possible exposures with the use of condoms or needle exchange programs, women knew they could not control all their potential exposures, misinformation and incomplete information affected women's ability to assess their exposures, and perceptions of potential for infection were dynamic and dependent on current priorities in their lives. Conclusions: Women assessed their possibility for HIV based on their perception of control, their access to information, and based on life circumstances. Understanding how women think about their potential for infection can allow healthcare professionals to better counsel women on their chances of HIV transmission, leading to greater HIV prevention.

  • Open Access

    Perspectives on PrEP/PEP Integration in Telehealth Gender-Affirming Care: A Survey of Clients From a National Telehealth Platform

    by Nancy Aitcheson, Yun Li, Yixuan Feng, Caroline S O'BRien, Moira Kyweluk, Nadia Dowshen, Florence Momplaisir

    Background: Transgender individuals face disproportionate HIV burden yet experience significant barriers to accessing biomedical HIV prevention. We assessed awareness, experience, and willingness among trans adults to use pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) when integrated with telehealth-delivered gender-affirming hormone care (GAC). Methods: We conducted a cross-sectional survey of clients receiving GAHC via a national subscription-based telehealth platform between October 2023 and January 2024. Using stratified sampling to ensure inclusion of transgender men (TGM) and those residing in rural areas, we assessed PrEP/PEP awareness, prior use, barriers, and willingness to use these services if recommended by their GAC provider. Multivariable logistic regression identified factors associated with stated willingness (yes/no). Results: Among 387 respondents (from 2506 survey invitations, 15.4% response rate), 54.8% identified as transgender women (TGW), 45% were between the ages of 18 and 25, and 74% identified as white, and 13% resided in rural areas. Pre-exposure prophylaxis awareness was moderate among TGW (56%) and TGM (69%), while PEP awareness was 24% among TGW and 31% among TGM. Only 2% of TGW were using PrEP (0% of TGM), and 0% had used PEP. Despite limited prior utilization, 67% expressed willingness to use PrEP and 66% willingness to use PEP if recommended by their GAC provider. Public insurance (vs private) and self-reported HIV worry (vs not worried) were associated with willingness to use both PrEP (public insurance: aOR 3.64, P = .022; HIV worry: aOR 2.57, P = .002) and PEP (public insurance: aOR 3.48, P = .032; HIV worry: aOR 2.41, P = .004). Prior awareness of PEP was also associated with willingness to use it (aOR 2.06, 95% CI 1.08–3.94, P = .030). Conclusions: Among clients of a subscription-based telehealth platform, stated acceptability of integrated PrEP/PEP services was high regardless of gender identity or geography. Limited awareness, cost concerns, and the large gap between awareness and utilization require further attention to realize the potential benefits of biomedical HIV prevention integration into telehealth GAC.

  • Open Access

    Traumatic birth experiences and maternal caregiving behaviors and attitudes in black and white women

    by Sara L. Kornfield, Nicole M. Henry, Rebecca Waller, Lauren White, Raquel Gur, Deiriai Myers, Kate Wisniewski, Florence Momplaisir, Wanjikũ F. M. Njoroge

    Purpose: This longitudinal investigation examined the association between traumatic birth experiences (measured via self-report and clinician-report) and caregiving behaviors and attitudes and any race-related differences in these associations. Methods: Subjective childbirth trauma was measured via a three-item questionnaire at 12 weeks postpartum. Medical childbirth factors were extracted from the electronic health record. Maternal caregiving behaviors and attitudes were assessed via comprehensive questionnaires (i.e., mother-infant bonding and parenting stress) and observation ratings (i.e., positive parenting and mother-infant interactions) at 12 weeks, 12 months, and 24 months postpartum. Multiple linear regressions were run to analyze these relationships. Results: A total of 255 mothers (106 Black and 149 White) who gave birth from April to December 2020 were examined. More traumatic childbirth experiences were significantly associated with higher-rated observed positive parenting scores ( β = 0.21, p FDR <0.05) when controlling for demographic factors. There were no significant relationships at 12 weeks or 24 months postpartum. Additionally, there were no effects of race on the relationship between childbirth trauma and caregiving. Conclusions: Subjective reports of childbirth trauma were not significantly associated with poorer maternal caregiving behaviors and attitudes. This study adds to the literature by examining Black women, as they are underrepresented in this body of research and more at risk of experiencing traumatic childbirths.


  • Open Access

    Women in the HIV Care Continuum: Assessing Re-linking Women to Care and Maintaining Viral Suppression Postpartum in Philadelphia from 2012 to 2023

    by Kira J. Nightingale, Tanner Nassau, Antoneta Karaj, John H. Holmes, Yun Li, Florence M. Momplaisir, Kathleen A. Brady, Elizabeth D. Lowenthal

    The purpose of this study was to describe the HIV care continuum postpartum in a cohort of postpartum women with HIV (WWH) in Philadelphia, and assess the impact of the City’s perinatal case management (PCM) program on engagement in the HIV care continuum. A cohort of 937 mothers who gave birth between 1/1/2012 and 12/31/2023 and who lived, gave birth, or received perinatal and pediatric care in Philadelphia, PA were enrolled. Using public health surveillance data, the impact of PCM use on engagement in care at 90 days postpartum, retention in care at 1-year postpartum, and viral suppression at 1-year postpartum was assessed using logistic regression with robust standard errors. Overall, 51.1%, 65.4%, and 42.0% of the population was engaged in care at 90 days, and retained in care and virally suppressed at 1-year, respectively. A larger percentage of PCM users than non-users were engaged in care at 90 days (56.4% versus 43.9%) and retained in care (73.2% versus 59.2%) and virally suppressed (48.2% versus 37.1%) at 1 year. After controlling for confounders, PCM use was significantly associated with increased engagement in care at 90 days (aOR = 1.403 [1.030–1.913]), retention in care at 1 year (aOR = 1.576 [1.163–2.136]), and viral suppression at 1 year (aOR = 1.412 [1.060–1.881]). Philadelphia’s PCM program is effective in improving engagement in the HIV care continuum during the postpartum period. Other US cities, particularly those with high HIV prevalence, should consider adopting a similar city-funded PCM program for pregnant and postpartum WWH.


  • Open Access

    Reduced Adherence to Antiretroviral Therapy in Pregnant Women With HIV With Intimate Partner Violence in the United States

    by Aasith Villavicencio, John B Jemmott, Fatemeh Ghadimi, Hervette Nkwihoreze, Sara Seyedroudbari, William R Short, Aadia Rana, Anandi N Sheth, Rachel K Scott, Gweneth B Lazenby, et al.

    Background: Despite increased access to antiretroviral therapy (ART) for women with HIV (WWH), poor postpartum HIV care retention persists. This analysis evaluates Intimate Partner Violence (IPV) and ART adherence in pregnant WWH. Methods: We analyzed secondary data from a US behavioral intervention trial to improve postpartum retention in WWH. Data were collected from the baseline survey including the Edinburgh Postnatal Depression Scale (EPDS), adverse childhood experiences (ACE), and HIV-related stigma scores, and the WHO Violence Against Women questionnaire to assess IPV. A multivariable logistic regression examined associations between IPV timing (before, during pregnancy, any) and type (physical, psychological, sexual) and ART adherence (≥80% ART doses in the prior month). Results: A total of 137 pregnant WWH enrolled between March 2020 and March 2024 were included: mean age was 30.5 (SD 5.6); 83% were Black, 14% Hispanic; mean number of pregnancies was 3.3 (SD 2.1). Depression, stigma, and ACEs were prevalent: EPDS scores of ≥10 were seen in 45% of women, ≥4 ACEs in 23%, and 51% reported HIV-related shame. Forty women (29%) reported IPV exposure. Higher EPDS, ACE, and stigma scores were seen in women exposed to IPV (P < .02). Physical IPV during pregnancy had the strongest association with decreased ART adherence in pregnancy (adjusted odds ratio = 0.10, P = .02). Psychological IPV and any IPV type during or before pregnancy were also associated with lower odds of adherence. Conclusions: We found high IPV rates and a significant negative association with ART adherence among pregnant WWH highlighting the importance of addressing IPV in HIV care.

  • Authors’ Response to Letter to the Editor, re: 10.1089/apc.2024.0159

    by Tiffany Yuh, Florence Momplaisir, Helen Koenig

  • Acceptability and Feasibility of Implementing a Home-Based HIV Pre-Exposure Prophylaxis Program in an Urban Clinic

    by Tiffany Yuh, Linden Lalley-Chareczko, Dante’ Zanders, Harlan Shaw, Terrence Spencer, Dana Serafin, Helen Koenig, Florence Momplaisir

    Personal and structural barriers to HIV pre-exposure prophylaxis (PrEP) care result in its underutilization and premature discontinuation. A home-based PrEP program comprised of telemedicine visits and/or self-administered lab testing may address some of these barriers. Our objective was to assess the acceptability and feasibility of a home-based PrEP program among stakeholders at an urban HIV and primary care clinic. We used the consolidated framework for implementation research to evaluate determinants of successful implementation of the program. We surveyed and interviewed PrEP patients and their health care team. In a baseline survey of PrEP users ( n = 112) administered between May 2021 and August 2022, 65% expressed interest in switching to the home-based PrEP program. Seventeen patients over the course of follow-up through December 2023 started home-based PrEP, including 12 patients who completed both a telemedicine visit and a self-administered lab kit, and 5 patients who completed only a telemedicine visit. Of these, over 80% had positive feedback on the telemedicine visits. Survey results demonstrated excellent acceptability and feasibility of the lab kits. Patients indicated in interviews that the home-based PrEP program provided the strong advantage of convenience. Despite mixed feelings from PrEP providers on telemedicine visits ( n = 5), most felt that the program made PrEP care delivery easier for patients and would encourage their patients to use the program if it were a good fit. Barriers to program success included shipping delays and staff turnover during program implementation. In conclusion, uptake of the home-based program was low but program participants expressed high acceptability.


  • Barriers and Facilitators to Long-Acting Injectable HIV Pre-Exposure Prophylaxis Implementation in Primary Care Since Its Approval in the United States

    by Shimrit Keddem, Sneha Thatipelli, Omaris Msph Caceres, Navid Roder, Florence Md Momplaisir, Peter Cronholm

    Background: HIV pre-exposure prophylaxis (PrEP) is a highly effective method to mitigate the HIV epidemic, but uptake of PrEP has been slow and is associated with racial and gender disparities. Oral PrEP requires high levels of adherence to be effective, which may disadvantage certain high-risk groups. The first injectable HIV PrEP, a drug given every 2 months rather than as a daily pill, was approved by the US Food & Drug Administration in December 2021. Setting: A Family Medicine practice in a single health organization in the United States (November 2022 to February 2023). Methods: We conducted interviews with patients and key stakeholders to characterize factors affecting long-acting injectable (LAI) PrEP implementation. Data collection and analysis were guided by the Consolidated Framework for Implementation Research. Interviews were transcribed and analyzed using guided content analysis. Results: Twenty-five patients (n = 13) and practice stakeholders (n = 12) were interviewed. Overall, stakeholders described a very low uptake of LAI PrEP. Barriers to LAI PrEP included a lack of awareness, insurance and access issues, a lack of streamlined workflow, and a trust in pills over injectables. Facilitators to LAI PrEP implementation included the absence of a pill burden, a culture of shared decision making, and pharmacy support. Conclusions: Although uptake has been slow, we have identified several promising strategies for improving rollout and implementation of LAI PrEP. Approaches that can bolster rollout of LAI PrEP include having an interdisciplinary care team that is supported by PrEP navigators and pharmacists and are informed by a patient-centered model of care to increase patient engagement and trust.


  • Open Access

    Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce

    by Florence Momplaisir, Tanya Rogo, Ronika Alexander Parrish, Shirley Delair, Mona Rigaud, Virginia Caine, Judith Absalon, Bonnie Word, Dial Hewlett

    On 29 June 2023, the Supreme Court of the United States ruled that race-conscious consideration for college admission is unconstitutional. We discuss the consequences of this ruling on the delivery of equitable care and health system readiness to combat current and emerging pandemics. We propose strategies to mitigate the negative impact of this ruling on diversifying the infectious disease (ID) workforce.


  • Open Access

    HIV pre‐exposure prophylaxis programme preferences among sexually active HIV‐negative transgender and gender diverse adults in the United States: a conjoint analysis

    by Dovie L. Watson, Louis Listerud, Ryan A. Drab, Willey Y. Lin, Florence Marie Momplaisir, José A. Bauermeister

    Introduction: Current implementation efforts have failed to achieve equitable HIV pre‐exposure prophylaxis (PrEP) provision for transgender and gender‐diverse (trans) populations. We conducted a choice‐based conjoint analysis to measure preferences for key attributes of hypothetical PrEP delivery programmes among a diverse online sample predominantly comprised of transmasculine and nonbinary individuals in the United States.Methods: Between April 2022 and June 2022, a national online survey with an embedded conjoint analysis experiment was conducted among 304 trans individuals aged ≥18 years in the United States to assess five PrEP programme attributes: out‐of‐pocket cost; dispensing venue; frequency of visits for PrEP‐related care; travel time to PrEP provider; and ability to bundle PrEP‐related care with gender‐affirming hormone therapy services. Participants responded to five questions, each of which presented two PrEP programme scenarios and one opt‐out option per question and selected their preferred programme in each question. We used hierarchical Bayes estimation and multinomial logistic regression to measure part‐worth utility scores for the total sample and by respondents’ PrEP status.Results: The median age was 24 years (range 18–56); 75% were assigned female sex at birth; 54% identified as transmasculine; 32% as nonbinary; 14% as transfeminine. Out‐of‐pocket cost had the highest attribute importance score (44.3%), followed by the ability to bundle with gender‐affirming hormone therapy services (18.7%). Minimal cost‐sharing ($0 out‐of‐pocket cost) most positively influenced the attribute importance of cost (average conjoint part‐worth utility coefficient of 2.5 [95% CI 2.4−2.6]). PrEP‐experienced respondents preferred PrEP delivery in primary care settings (relative utility score 4.7); however, PrEP‐naïve respondents preferred pharmacies (relative utility score 5.1).Conclusions: Participants preferred programmes that offered PrEP services without cost‐sharing and bundled with gender‐affirming hormone therapy services. Bolstering federal regulations to cover PrEP services and prioritizing programmes to expand low‐barrier PrEP provision are critical to achieving equitable PrEP provision. Community‐engaged implementation research conducted by and in close collaboration with trans community stakeholders and researchers are needed to streamline the design of patient‐centred PrEP programmes and develop implementation strategies that are salient to the diverse sexual health needs of trans patients.